399 related articles for article (PubMed ID: 11034588)
21. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
[TBL] [Abstract][Full Text] [Related]
24. Recurrence of hepatitis C virus after liver transplantation.
Gugenheim J; Baldini E; Mazza D; Fabiani P; St Paul MC; Goubaux B; Ouzan D; Mouiel J
Transpl Int; 1994; 7 Suppl 1():S224-6. PubMed ID: 11271209
[TBL] [Abstract][Full Text] [Related]
25. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients.
Villa E; Grottola A; Buttafoco P; Merighi A; Ferretti I; Trande P; Zoboli P; Camellini L; Callea F; De Palma M
Clin Transplant; 1995 Jun; 9(3 Pt 1):160-4. PubMed ID: 7549054
[TBL] [Abstract][Full Text] [Related]
27. [Antibodies to different virus antigens in patients with chronic hepatitis C].
Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of hepatitis C virus infection after liver transplantation.
Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection.
Pageaux GP; Ducos J; Mondain AM; Costes V; Picot MC; Perrigault PF; Domergue J; Larrey D; Michel H
Liver Transpl Surg; 1997 Sep; 3(5):501-5. PubMed ID: 9346792
[TBL] [Abstract][Full Text] [Related]
31. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen.
Vargas V; Krawczynski K; Castells L; Martinez N; Esteban J; Allende H; Esteban R; Guardia J
Liver Transpl Surg; 1998 Jul; 4(4):320-7. PubMed ID: 9649647
[TBL] [Abstract][Full Text] [Related]
32. Incidence and outcome of hepatitis C virus infection after liver transplantation.
Vargas V; Comas P; Castells L; Quer J; Esteban JI; Allende E; Esteban R; Guardia J; Margarit C
Transpl Int; 1994; 7 Suppl 1():S216-20. PubMed ID: 11271206
[TBL] [Abstract][Full Text] [Related]
33. Reinfection of liver graft by hepatitis C virus after liver transplantation.
Féray C; Samuel D; Thiers V; Gigou M; Pichon F; Bismuth A; Reynes M; Maisonneuve P; Bismuth H; Bréchot C
J Clin Invest; 1992 Apr; 89(4):1361-5. PubMed ID: 1313453
[TBL] [Abstract][Full Text] [Related]
34. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
35. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
[TBL] [Abstract][Full Text] [Related]
36. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
37. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
38. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
39. Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation.
Trak-Smayra V; Contreras J; Dondero F; Durand F; Dubois S; Sommacale D; Marcellin P; Belghiti J; Degott C; Paradis V
Transplantation; 2004 Jun; 77(11):1755-60. PubMed ID: 15201678
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
